International | Tissuepathology.com

EVIDENT Announces 6th Annual Image of the Year Award Winners

Erica Goodpaster — Wed, 29 Apr 2026 13:25:16 +0000

EVIDENT: Star-like neurospheres brilliantly connect our inner and outer worlds NEEDHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) — Evident unveiled the winners of its sixth annual Image of the Year contest, an awards competition that recognizes the world’s best in scientific microscopic imaging. The winners were selected from submissions from 34 countries around the world. Global […]

The post EVIDENT Announces 6th Annual Image of the Year Award Winners first appeared on Tissuepathology.com.

HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California

Erica Goodpaster — Tue, 28 Apr 2026 11:50:17 +0000

SINGAPORE, April 28, 2026 /PRNewswire/ — HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnership network in the United States with the addition of two new hepatology and gastroenterology centers – Houston Research Institute (HRI) Kingwood and Knowledge Research Center (KRC) in Orange, California. HistoIndex […]

The post HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California first appeared on Tissuepathology.com.

Fimlab expands utilization of Aiforia’s clinical AI solutions

Erica Goodpaster — Mon, 27 Apr 2026 12:10:53 +0000

Fimlab Laboratories expands the use of Aiforia’s AI solutions for breast cancer diagnostics, bringing multi-organ Ki67 biomarker quantification into routine clinical use. Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m. EEST Aiforia Technologies Plc announced today that Fimlab Laboratories in Finland has expanded the use of Aiforia’s AI solutions in routine clinical […]

The post Fimlab expands utilization of Aiforia’s clinical AI solutions first appeared on Tissuepathology.com.

Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026

Erica Goodpaster — Fri, 24 Apr 2026 12:37:33 +0000

CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual Meeting 2026, further proving its unique capability to unlock complete biological blueprints essential for drug discovery and clinical decision-making. The Company revealed […]

The post Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026 first appeared on Tissuepathology.com.

Aiforia closes a deal with a private diagnostic laboratory in Italy

Erica Goodpaster — Thu, 23 Apr 2026 12:22:10 +0000

Using Aiforia Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST Aiforia Technologies Plc has signed an agreement with Laboratorio di Analisi La Fontana, a private diagnostic laboratory in Italy, to collaborate in AI-powered digital pathology. […]

The post Aiforia closes a deal with a private diagnostic laboratory in Italy first appeared on Tissuepathology.com.

Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application

Erica Goodpaster — Mon, 20 Apr 2026 11:32:31 +0000

Lunit: AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor microenvironment not captured by conventional methods, and enable integrated analysis to better support treatment decision-making. SEOUL, South Korea, April 17, 2026 /PRNewswire/ — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, […]

The post Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application first appeared on Tissuepathology.com.